{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:46:40Z","timestamp":1787168800533,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Scientific Research Funding Authority at Helwan University."},{"DOI":"10.13039\/501100003789","name":"Helwan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003789","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Multiple sclerosis (MS) and Neuromyelitis Optica (NMO) are immune-related CNS inflammatory diseases that often present with overlapping clinical symptoms, leading to frequent misdiagnosis, particularly in aquaporin-4 seronegative NMO patients. Identifying the underlying mechanisms of these diseases is critical for discovering biomarkers that enable timely diagnosis and effective treatment. This study included 252 participants, divided into four groups.\n                    <jats:bold>Group I<\/jats:bold>\n                    (Relapsing\u2013Remitting MS: RRMS group),\n                    <jats:bold>Group II<\/jats:bold>\n                    (Secondary Progressive MS: SPMS group),\n                    <jats:bold>Group III<\/jats:bold>\n                    (NMO group), and\n                    <jats:bold>Group IV<\/jats:bold>\n                    (Healthy controls). Blood samples were collected from all participants to measure the expression levels of Neuregulin-1 (NRG1),\n                    <jats:italic>lncRNA Ftx,<\/jats:italic>\n                    and\n                    <jats:italic>miR-382-5p<\/jats:italic>\n                    . The results showed that NRG1 levels were significantly lower in the RRMS, SPMS, NMO groups compared to healthy controls, with the most pronounced reduction observed in NMO, suggesting NRG1 may serve as a potential biomarker for differentiating NMO from MS, especially in cases where traditional diagnostic criteria are inconclusive.\n                    <jats:italic>lncRNA Ftx<\/jats:italic>\n                    , a sponge for\n                    <jats:italic>miR-382-5p<\/jats:italic>\n                    , exhibited an opposite trend to miR-382-5p and was significantly downregulated in NMO compared to MS, SPMS, RRMS, and healthy controls, suggesting its potential as a promising biomarker. Our findings highlight the potential of NRG1, lncRNA Ftx, and miR-382-5p expression as diagnostic, screening, and prognostic biomarkers, as well as tools for the differential diagnosis of NMO and MS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10753-025-02284-7","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T02:11:11Z","timestamp":1743991871000},"page":"3560-3578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Inflammatory Axis of LncRNA Ftx\/miR-382-5p\/NRG1 in the Differential Diagnosis and Prognosis of Multiple Sclerosis and Neuromyelitis Optica"],"prefix":"10.1007","volume":"48","author":[{"given":"Nadia","family":"Mangoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shady","family":"Estfanous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2284_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson, R., and G. Giovannoni. 2019. Multiple sclerosis \u2013 a review. European Journal of Neurology 26: 27\u201340. https:\/\/doi.org\/10.1111\/ene.13819.","journal-title":"European Journal of Neurology"},{"issue":"6578","key":"2284_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik, K., et al. 2023. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375 (6578): 296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222.","journal-title":"Science"},{"issue":"12","key":"2284_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield, K.E., L.T. Jensen, M. Kaufmann, M.A. Friese, and L. Fugger. 2022. The immunology of multiple sclerosis. Nature Reviews Immunology 22 (12): 734\u2013750. https:\/\/doi.org\/10.1038\/s41577-022-00718-z.","journal-title":"Nature Reviews Immunology"},{"issue":"14","key":"2284_CR4","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C., et al. 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis Journal 26 (14): 1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841.","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"2284_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-022-01013-y","volume":"81","author":"Z Afifi","year":"2023","unstructured":"Afifi, Z., A. Hassan, N. Abdelrahman, A. El Sayed, and M. Salem. 2023. Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019\u20132020: Randomized controlled clinical trial. Arch. Public Heal 81 (1): 1\u201312. https:\/\/doi.org\/10.1186\/s13690-022-01013-y.","journal-title":"Arch. Public Heal"},{"issue":"November","key":"2284_CR6","doi-asserted-by":"publisher","first-page":"154880","DOI":"10.1016\/j.prp.2023.154880","volume":"251","author":"AS Doghish","year":"2023","unstructured":"Doghish, A.S., et al. 2023. The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance. Pathology - Research and Practice 251 (November): 154880. https:\/\/doi.org\/10.1016\/j.prp.2023.154880.","journal-title":"Pathology - Research and Practice"},{"issue":"4","key":"2284_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028944","volume":"9","author":"L Alfredsson","year":"2019","unstructured":"Alfredsson, L., and T. Olsson. 2019. Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harbor Perspectives in Medicine 9 (4): a028944. https:\/\/doi.org\/10.1101\/cshperspect.a028944.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"3","key":"2284_CR8","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ijms23031664","volume":"23","author":"N Cuomo-Haymour","year":"2022","unstructured":"Cuomo-Haymour, N., et al. 2022. Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis: disease-stage specificity and relevance to pathophysiology. International Journal of Molecular Sciences 23 (3): 1664. https:\/\/doi.org\/10.3390\/ijms23031664.","journal-title":"International Journal of Molecular Sciences"},{"key":"2284_CR9","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2147\/NDT.S429862","volume":"19","author":"D Zimek","year":"2023","unstructured":"Zimek, D., M. Miklusova, and J. Mares. 2023. Overview of the current pathophysiology of fatigue in multiple sclerosis, its diagnosis and treatment options \u2013 review article. Neuropsychiatric Disease and Treatment 19: 2485\u20132497. https:\/\/doi.org\/10.2147\/NDT.S429862.","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"2284_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22265-2","volume":"12","author":"A Eshaghi","year":"2021","unstructured":"Eshaghi, A., et al. 2021. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications 12 (1): 1\u201312. https:\/\/doi.org\/10.1038\/s41467-021-22265-2.","journal-title":"Nature Communications"},{"issue":"4","key":"2284_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/CLINMED.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford, H. 2020. Clinical presentation and diagnosis of multiple sclerosis. Clinical Medicine Physicians London 20 (4): 380\u2013383. https:\/\/doi.org\/10.7861\/CLINMED.2020-0292.","journal-title":"Clinical Medicine Physicians London"},{"issue":"1","key":"2284_CR12","doi-asserted-by":"publisher","first-page":"8718736","DOI":"10.1155\/2020\/8718736","volume":"2020","author":"C Rodney","year":"2020","unstructured":"Rodney, C., S. Rodney, and R.M. Millis. 2020. Vitamin D and demyelinating diseases: neuromyelitis optica (NMO) and Multiple Sclerosis (MS). Autoimmune Dis 2020 (1): 8718736. https:\/\/doi.org\/10.1155\/2020\/8718736.","journal-title":"Autoimmune Dis"},{"issue":"9","key":"2284_CR13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1177\/1352458517703803","volume":"23","author":"JI Kira","year":"2017","unstructured":"Kira, J.I. 2017. Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others? Multiple Sclerosis 23 (9): 1300\u20131302. https:\/\/doi.org\/10.1177\/1352458517703803.","journal-title":"Multiple Sclerosis"},{"key":"2284_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/J.MSARD.2018.12.002","volume":"27","author":"Y Wu","year":"2019","unstructured":"Wu, Y., L. Zhong, and J. Geng. 2019. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models. Multiple Sclerosis and Related Disorders 27: 412\u2013418. https:\/\/doi.org\/10.1016\/J.MSARD.2018.12.002.","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"2","key":"2284_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/biomedicines7020042","volume":"7","author":"MA Lana-Peixoto","year":"2019","unstructured":"Lana-Peixoto, M.A., and N. Talim. 2019. Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes. Biomedicines 7 (2): 42. https:\/\/doi.org\/10.3390\/biomedicines7020042.","journal-title":"Biomedicines"},{"issue":"5","key":"2284_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10799893.2020.1830109","volume":"41","author":"J Wang","year":"2021","unstructured":"Wang, J., J. Liu, R. Li, and C. Wang. 2021. Research and progress on biomarkers of neuromyelitis optica spectrum disorders. Journal of Receptor and Signal Transduction Research 41 (5): 417\u2013424.","journal-title":"Journal of Receptor and Signal Transduction Research"},{"key":"2284_CR17","doi-asserted-by":"publisher","first-page":"101643","DOI":"10.1016\/J.PNEUROBIO.2019.101643","volume":"180","author":"H Kataria","year":"2019","unstructured":"Kataria, H., A. Alizadeh, and S. Karimi-Abdolrezaee. 2019. Neuregulin-1\/ErbB network: An emerging modulator of nervous system injury and repair. Progress in neurobiology 180: 101643. https:\/\/doi.org\/10.1016\/J.PNEUROBIO.2019.101643.","journal-title":"Progress in neurobiology"},{"issue":"3","key":"2284_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/glia.23264","volume":"66","author":"H Kataria","year":"2018","unstructured":"Kataria, H., et al. 2018. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord. Glia 66 (3): 538\u2013561. https:\/\/doi.org\/10.1002\/glia.23264.","journal-title":"Glia"},{"issue":"1","key":"2284_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/brain\/awaa385","volume":"144","author":"H Kataria","year":"2021","unstructured":"Kataria, H., et al. 2021. Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis. Brain 144 (1): 162\u2013185. https:\/\/doi.org\/10.1093\/brain\/awaa385.","journal-title":"Brain"},{"issue":"4","key":"2284_CR20","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.3390\/ijms25042268","volume":"25","author":"AK Anilkumar","year":"2024","unstructured":"Anilkumar, A.K., et al. 2024. Long Non-Coding RNAs: New insights in neurodegenerative diseases. International Journal of Molecular Sciences 25 (4): 2268. https:\/\/doi.org\/10.3390\/ijms25042268.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"2284_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s13402-023-00806-9","volume":"46","author":"R Bhattacharjee","year":"2023","unstructured":"Bhattacharjee, R., et al. 2023. Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology 46 (4): 885\u2013908. https:\/\/doi.org\/10.1007\/s13402-023-00806-9.","journal-title":"Cellular Oncology"},{"issue":"May 2020","key":"2284_CR22","doi-asserted-by":"publisher","first-page":"104929","DOI":"10.1016\/j.neuint.2020.104929","volume":"143","author":"W Xiang","year":"2021","unstructured":"Xiang, W., et al. 2021. The lncRNA Ftx\/miR-382\u20135p\/Nrg1 axis improves the inflammation response of microglia and spinal cord injury repair. Neurochemistry International 143 (May 2020): 104929. https:\/\/doi.org\/10.1016\/j.neuint.2020.104929.","journal-title":"Neurochemistry International"},{"issue":"2","key":"2284_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A.J., et al. 2018. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology 17 (2): 162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2.","journal-title":"Lancet Neurology"},{"issue":"5","key":"2284_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000002366","volume":"86","author":"CT Tan","year":"2016","unstructured":"Tan, C.T. 2016. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 86 (5): 491\u2013492. https:\/\/doi.org\/10.1212\/WNL.0000000000002366.","journal-title":"Neurology"},{"issue":"5","key":"2284_CR25","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1111\/ejn.12268","volume":"38","author":"M-K Gauthier","year":"2013","unstructured":"Gauthier, M.-K., K. Kosciuczyk, L. Tapley, and S. Karimi-Abdolrezaee. 2013. Dysregulation of the neuregulin-1-ErbB network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury. European Journal of Neuroscience 38 (5): 2693\u20132715. https:\/\/doi.org\/10.1111\/ejn.12268.","journal-title":"European Journal of Neuroscience"},{"key":"2284_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105442","volume":"157","author":"C Navarro-Gonzalez","year":"2021","unstructured":"Navarro-Gonzalez, C., et al. 2021. Nrg1 haploinsufficiency alters inhibitory cortical circuits. Neurobiology of Diseases 157: 105442. https:\/\/doi.org\/10.1016\/j.nbd.2021.105442.","journal-title":"Neurobiology of Diseases"},{"issue":"2","key":"2284_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000370075","volume":"71","author":"P Su\u00e1rez-Pinilla","year":"2015","unstructured":"Su\u00e1rez-Pinilla, P., et al. 2015. Progressive structural brain changes and NRG1 gene variants in first-episode nonaffective psychosis. Neuropsychobiology 71 (2): 103\u2013111. https:\/\/doi.org\/10.1159\/000370075.","journal-title":"Neuropsychobiology"},{"key":"2284_CR28","doi-asserted-by":"publisher","first-page":"3930186","DOI":"10.1155\/2019\/3930186","volume":"2019","author":"C Navarro-Gonz\u00e1lez","year":"2019","unstructured":"Navarro-Gonz\u00e1lez, C., A. Huerga-G\u00f3mez, and P. Fazzari. 2019. Nrg1 Intracellular signaling is neuroprotective upon stroke. Oxidative Medicine and Cellular Longevity 2019: 3930186. https:\/\/doi.org\/10.1155\/2019\/3930186.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"10","key":"2284_CR29","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.scib.2024.02.017","volume":"69","author":"L-H Lin","year":"2024","unstructured":"Lin, L.-H., et al. 2024. Medial amygdala NRG1 signaling mediates adolescent social isolation-induced autistic-like behaviors. Science Bulletin 69 (10): 1375\u20131379. https:\/\/doi.org\/10.1016\/j.scib.2024.02.017.","journal-title":"Science Bulletin"},{"issue":"1","key":"2284_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41598-017-00207-7","volume":"7","author":"J-M Zhu","year":"2017","unstructured":"Zhu, J.-M., et al. 2017. Increased NRG1-ErbB4 signaling in human symptomatic epilepsy. Science and Reports 7 (1): 141. https:\/\/doi.org\/10.1038\/s41598-017-00207-7.","journal-title":"Science and Reports"},{"issue":"1","key":"2284_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12964-024-01528-7","volume":"22","author":"R Mao","year":"2024","unstructured":"Mao, R., et al. 2024. Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer\u2019s disease. Cell Communication and Signaling: CCS 22 (1): 147. https:\/\/doi.org\/10.1186\/s12964-024-01528-7.","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"12","key":"2284_CR32","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.annonc.2020.08.2335","volume":"31","author":"J Laskin","year":"2020","unstructured":"Laskin, J., et al. 2020. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Annals of Oncology 31 (12): 1693\u20131703. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2335.","journal-title":"Annals of Oncology"},{"issue":"1","key":"2284_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13058-020-01377-5","volume":"23","author":"KD Howarth","year":"2021","unstructured":"Howarth, K.D., et al. 2021. NRG1 fusions in breast cancer. Breast Cancer Research 23 (1): 3. https:\/\/doi.org\/10.1186\/s13058-020-01377-5.","journal-title":"Breast Cancer Research"},{"key":"2284_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115920","volume":"218","author":"G Hou","year":"2023","unstructured":"Hou, G., et al. 2023. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma. Biochemical Pharmacology 218: 115920. https:\/\/doi.org\/10.1016\/j.bcp.2023.115920.","journal-title":"Biochemical Pharmacology"},{"key":"2284_CR35","doi-asserted-by":"publisher","first-page":"103527","DOI":"10.1016\/j.msard.2022.103527","volume":"59","author":"C-C Fu","year":"2022","unstructured":"Fu, C.-C., et al. 2022. Serum molecular biomarkers in neuromyelitis optica and multiple sclerosis. Multiple Sclerosis and Related Disorders 59: 103527. https:\/\/doi.org\/10.1016\/j.msard.2022.103527.","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"13","key":"2284_CR36","doi-asserted-by":"publisher","first-page":"1037812","DOI":"10.3389\/fimmu.2022.1037812","volume":"14","author":"A Bauer","year":"2022","unstructured":"Bauer, A., et al. 2022. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Frontiers in Immunology 14 (13): 1037812. https:\/\/doi.org\/10.3389\/fimmu.2022.1037812.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2284_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/15257770.2023.2243289","volume":"43","author":"E Kioumarsi","year":"2024","unstructured":"Kioumarsi, E., L. Kohan, F. Noorbakhsh, S. Shirian, A. Gorji, and A. Zare-Chahoki. 2024. Involvement of NRON and TUG1 long noncoding RNAs in inflammation and the pathogenesis of EAE. Nucleosides, Nucleotides & Nucleic Acids 43 (2): 146\u2013155. https:\/\/doi.org\/10.1080\/15257770.2023.2243289.","journal-title":"Nucleosides, Nucleotides & Nucleic Acids"},{"issue":"12","key":"2284_CR38","doi-asserted-by":"publisher","first-page":"e32685","DOI":"10.1016\/j.heliyon.2024.e32685","volume":"10","author":"R Al-Temaimi","year":"2024","unstructured":"Al-Temaimi, R., and R. Alroughani. 2024. miR-24\u20133p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis. Heliyon 10 (12): e32685. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32685.","journal-title":"Heliyon"},{"issue":"1","key":"2284_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ana.26650","volume":"94","author":"Y Xie","year":"2023","unstructured":"Xie, Y., et al. 2023. Astrocyte-derived exosomes contribute to pathologies of neuromyelitis optica spectrum disorder in rodent model. Annals of Neurology 94 (1): 163\u2013181. https:\/\/doi.org\/10.1002\/ana.26650.","journal-title":"Annals of Neurology"},{"key":"2284_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103078","volume":"53","author":"AA Elkhodiry","year":"2021","unstructured":"Elkhodiry, A.A., D.A. Zamzam, and H.M. El Tayebi. 2021. miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 53: 103078. https:\/\/doi.org\/10.1016\/j.msard.2021.103078.","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"6","key":"2284_CR41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000623","volume":"6","author":"S Kramer","year":"2019","unstructured":"Kramer, S., et al. 2019. Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study. Neurology Neuroimmunology & Neuroinflammation 6 (6): e623. https:\/\/doi.org\/10.1212\/NXI.0000000000000623.","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"issue":"1","key":"2284_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12974-016-0648-x","volume":"13","author":"A Vaknin-Dembinsky","year":"2016","unstructured":"Vaknin-Dembinsky, A., et al. 2016. Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO). Journal of Neuroinflammation 13 (1): 179. https:\/\/doi.org\/10.1186\/s12974-016-0648-x.","journal-title":"Journal of Neuroinflammation"},{"issue":"11","key":"2284_CR43","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.3390\/ijms24119127","volume":"24","author":"F Zobdeh","year":"2023","unstructured":"Zobdeh, F., et al. 2023. The epigenetics of migraine. International Journal of Molecular Sciences 24 (11): 9127. https:\/\/doi.org\/10.3390\/ijms24119127.","journal-title":"International Journal of Molecular Sciences"},{"key":"2284_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2013.03.011","volume":"55","author":"E Mor","year":"2013","unstructured":"Mor, E., S.-I. Kano, C. Colantuoni, A. Sawa, R. Navon, and N. Shomron. 2013. MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiology of Diseases 55: 1\u201310. https:\/\/doi.org\/10.1016\/j.nbd.2013.03.011.","journal-title":"Neurobiology of Diseases"},{"issue":"1","key":"2284_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12031-018-1067-5","volume":"65","author":"X Yao","year":"2018","unstructured":"Yao, X., Y. Wang, and D. Zhang. 2018. microRNA-21 confers neuroprotection against cerebral ischemia-reperfusion injury and alleviates blood-brain barrier disruption in rats via the MAPK signaling pathway. Journal of Molecular Neuroscience 65 (1): 43\u201353. https:\/\/doi.org\/10.1007\/s12031-018-1067-5.","journal-title":"Journal of Molecular Neuroscience"},{"key":"2284_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101612","volume":"73","author":"X Yin","year":"2022","unstructured":"Yin, X., W. Zheng, L. He, S. Mu, Y. Shen, and J. Wang. 2022. CircHIPK3 alleviates inflammatory response and neuronal apoptosis via regulating miR-382-5p\/DUSP1 axis in spinal cord injury. Transplant Immunology 73: 101612. https:\/\/doi.org\/10.1016\/j.trim.2022.101612.","journal-title":"Transplant Immunology"},{"key":"2284_CR47","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.2147\/OTT.S196322","volume":"12","author":"J Wang","year":"2019","unstructured":"Wang, J., C. Chen, X. Yan, and P. Wang. 2019. The role of miR-382-5p in glioma cell proliferation, migration and invasion. Oncotargets and Therapy 12: 4993\u20135002. https:\/\/doi.org\/10.2147\/OTT.S196322.","journal-title":"Oncotargets and Therapy"},{"key":"2284_CR48","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2147\/NDT.S243920","volume":"16","author":"S Li","year":"2020","unstructured":"Li, S., H. Ma, X. Yuan, X. Zhou, Y. Wan, and S. Chen. 2020. MicroRNA-382-5p targets nuclear receptor subfamily 3 Group C Member 1 to regulate depressive-like behaviors induced by chronic unpredictable mild stress in rats. Neuropsychiatric Disease and Treatment 16: 2053\u20132061. https:\/\/doi.org\/10.2147\/NDT.S243920.","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"12","key":"2284_CR49","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.joms.2022.08.016","volume":"80","author":"X Xu","year":"2022","unstructured":"Xu, X., B. Jin, L. Cai, Z. Zhang, Y. Ying, and J. Luo. 2022. MicroRNA-382-5p Promotes oral squamous cell carcinoma development and progression by negatively regulating PTEN Expression. Journal of Oral and Maxillofacial Surgery 80 (12): 2015\u20132023. https:\/\/doi.org\/10.1016\/j.joms.2022.08.016.","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"1","key":"2284_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12020-021-02847-2","volume":"75","author":"F Capriglione","year":"2022","unstructured":"Capriglione, F., et al. 2022. Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer. Endocrine 75 (1): 185\u2013193. https:\/\/doi.org\/10.1007\/s12020-021-02847-2.","journal-title":"Endocrine"},{"key":"2284_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2022.101582","volume":"27","author":"Z Derakhshan","year":"2022","unstructured":"Derakhshan, Z., G. Khamisipour, F.H. Soleimani, and N. Motamed. 2022. Serum MicroRNAs: -28-3p, -31-5p, -378a-3p, and -382-5p as novel potential biomarkers in acute lymphoblastic leukemia. Gene Reports 27: 101582. https:\/\/doi.org\/10.1016\/j.genrep.2022.101582.","journal-title":"Gene Reports"},{"issue":"4","key":"2284_CR52","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00204-020-02682-w","volume":"94","author":"CC Bell","year":"2020","unstructured":"Bell, C.C., et al. 2020. Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicity. Archives of Toxicology 94 (4): 1251\u20131263. https:\/\/doi.org\/10.1007\/s00204-020-02682-w.","journal-title":"Archives of Toxicology"},{"issue":"2","key":"2284_CR53","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.18632\/oncotarget.6444","volume":"7","author":"Y Bei","year":"2016","unstructured":"Bei, Y., et al. 2016. miR-382 targeting PTEN-Akt axis promotes liver regeneration. Oncotarget 7 (2): 1584\u20131597. https:\/\/doi.org\/10.18632\/oncotarget.6444.","journal-title":"Oncotarget"},{"issue":"3","key":"2284_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth, K., R. Bayraktar, M. Ferracin, and G.A. Calin. 2024. Non-coding RNAs in disease: From mechanisms to therapeutics. Nature Reviews Genetics 25 (3): 211\u2013232. https:\/\/doi.org\/10.1038\/s41576-023-00662-1.","journal-title":"Nature Reviews Genetics"},{"issue":"7","key":"2284_CR55","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.3390\/ijms25073630","volume":"25","author":"F Nappi","year":"2024","unstructured":"Nappi, F. 2024. Non-coding RNA-targeted therapy: a state-of-the-art review. International Journal of Molecular Sciences 25 (7): 3630. https:\/\/doi.org\/10.3390\/ijms25073630.","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"2284_CR56","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.4103\/1673-5374.306061","volume":"16","author":"V Nociti","year":"2021","unstructured":"Nociti, V., and M. Santoro. 2021. What do we know about the role of lncRNAs in multiple sclerosis? Neural Regeneration Research 16 (9): 1715\u20131722. https:\/\/doi.org\/10.4103\/1673-5374.306061.","journal-title":"Neural Regeneration Research"},{"key":"2284_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577347","volume":"347","author":"S Ghaderian","year":"2020","unstructured":"Ghaderian, S., et al. 2020. The emerging role of lncRNAs in multiple sclerosis. Journal of Neuroimmunology 347: 577347. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577347.","journal-title":"Journal of Neuroimmunology"},{"issue":"17","key":"2284_CR58","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.2147\/NDT.S337774","volume":"11","author":"Q Gao","year":"2021","unstructured":"Gao, Q., and Y. Wang. 2021. LncRNA FTX Regulates Angiogenesis Through miR-342-3p\/SPI1 Axis in Stroke. Neuropsychiatric Disease and Treatment 11 (17): 3617\u20133625. https:\/\/doi.org\/10.2147\/NDT.S337774.","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"6","key":"2284_CR59","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.26355\/eurrev_202003_20668","volume":"24","author":"F Zhang","year":"2020","unstructured":"Zhang, F., X.S. Wang, B. Tang, P.A. Li, Y. Wen, and P.W. Yu. 2020. Long non-coding RNA FTX promotes gastric cancer progression by targeting miR-215. European Review for Medical and Pharmacological Sciences 24 (6): 3037\u20133048. https:\/\/doi.org\/10.26355\/eurrev_202003_20668.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"17","key":"2284_CR60","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.21037\/atm-21-2755","volume":"9","author":"L Pan","year":"2021","unstructured":"Pan, L., et al. 2021. LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214\u20135p-JAG1 axis. Annals of Translational Medicine 9 (17): 1369. https:\/\/doi.org\/10.21037\/atm-21-2755.","journal-title":"Annals of Translational Medicine"},{"issue":"10","key":"2284_CR61","doi-asserted-by":"publisher","first-page":"e3237","DOI":"10.1002\/jgm.3237","volume":"22","author":"Y Liang","year":"2020","unstructured":"Liang, Y., and H. Lu. 2020. Long noncoding RNA FTX is associated with prognosis of glioma patients. The Journal of Gene Medicine 22 (10): e3237. https:\/\/doi.org\/10.1002\/jgm.3237.","journal-title":"The Journal of Gene Medicine"},{"issue":"1","key":"2284_CR62","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12885-021-07975-6","volume":"21","author":"S Li","year":"2021","unstructured":"Li, S., Q. Zhang, W. Liu, and C. Zhao. 2021. Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p. BMC Cancer 21 (1): 290. https:\/\/doi.org\/10.1186\/s12885-021-07975-6.","journal-title":"BMC Cancer"},{"issue":"8","key":"2284_CR63","first-page":"8833","volume":"13","author":"Y Shen","year":"2021","unstructured":"Shen, Y., G. Yang, S. Zhuo, H. Zhuang, and S. Chen. 2021. lncRNA FTX promotes asthma progression by sponging miR-590\u20135p and upregulating JAK2. American Journal of Translational Research 13 (8): 8833\u20138846.","journal-title":"American Journal of Translational Research"},{"issue":"22","key":"2284_CR64","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.21037\/atm-20-6810","volume":"8","author":"H Wang","year":"2020","unstructured":"Wang, H., C. Ni, W. Xiao, and S. Wang. 2020. Role of lncRNA FTX in invasion, metastasis, and epithelial-mesenchymal transition of endometrial stromal cells caused by endometriosis by regulating the PI3K\/Akt signaling pathway. Annals of Translational Medicine 8 (22): 1504. https:\/\/doi.org\/10.21037\/atm-20-6810.","journal-title":"Annals of Translational Medicine"},{"key":"2284_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2023.04.001","volume":"526","author":"G Zhang","year":"2023","unstructured":"Zhang, G., Y. Gao, L. Jiang, and Y. Zhang. 2023. LncRNA FTX Inhibits ferroptosis of hippocampal neurons displaying epileptiform discharges in vitro through the miR-142-5p\/GABPB1 Axis. Neuroscience 526: 48\u201360. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.04.001.","journal-title":"Neuroscience"},{"issue":"2","key":"2284_CR66","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s12640-022-00485-8","volume":"40","author":"W Wang","year":"2022","unstructured":"Wang, W., Y. Hu, and Y. Zhang. 2022. FTX attenuates cerebral ischemia-reperfusion injury by inhibiting apoptosis and oxidative stress via miR-186-5p\/MDM4 Pathway. Neurotoxicity Research 40 (2): 542\u2013552. https:\/\/doi.org\/10.1007\/s12640-022-00485-8.","journal-title":"Neurotoxicity Research"},{"issue":"6","key":"2284_CR67","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ajhg.2020.10.005","volume":"107","author":"EE Palmer","year":"2020","unstructured":"Palmer, E.E., et al. 2020. RLIM Is a candidate dosage-sensitive gene for individuals with varying duplications of Xq13, intellectual disability, and distinct facial features. American Journal of Human Genetics 107 (6): 1157\u20131169. https:\/\/doi.org\/10.1016\/j.ajhg.2020.10.005.","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"2284_CR68","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jds.2021.11.006","volume":"17","author":"H-F Tu","year":"2022","unstructured":"Tu, H.-F., C.-J. Liu, W.-W. Hung, and T.-M. Shieh. 2022. Co-upregulation of miR-31 and its host gene lncRNA MIR31HG in oral squamous cell carcinoma. J. Dent. Sci 17 (2): 696\u2013706. https:\/\/doi.org\/10.1016\/j.jds.2021.11.006.","journal-title":"J. Dent. Sci"},{"issue":"1","key":"2284_CR69","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1038\/s41467-023-43974-w","volume":"14","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y., et al. 2023. LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation. Nature Communications 14 (1): 8141. https:\/\/doi.org\/10.1038\/s41467-023-43974-w.","journal-title":"Nature Communications"},{"issue":"8","key":"2284_CR70","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41419-021-04021-y","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., et al. 2021. miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation. Cell Death & Disease 12 (8): 735. https:\/\/doi.org\/10.1038\/s41419-021-04021-y.","journal-title":"Cell Death & Disease"},{"issue":"5","key":"2284_CR71","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41591-024-02938-3","volume":"30","author":"CR Zamecnik","year":"2024","unstructured":"Zamecnik, C.R., G.M. Sowa, A. Abdelhak, R. Dandekar, R.D. Bair, K.J. Wade, C.M. Bartley, et al. 2024. An autoantibody signature predictive for multiple sclerosis. Nature medicine 30 (5): 1300\u20131308. https:\/\/doi.org\/10.1038\/s41591-024-02938-3.","journal-title":"Nature medicine"},{"issue":"15","key":"2284_CR72","doi-asserted-by":"publisher","first-page":"1401156","DOI":"10.3389\/fimmu.2024.1401156","volume":"28","author":"LA Ovchinnikova","year":"2024","unstructured":"Ovchinnikova, L.A., I.E. Eliseev, S.S. Dzhelad, T.O. Simaniv, K.M. Klimina, M. Ivanova, E.N. Ilina, et al. 2024. High heterogeneity of cross-reactive immunoglobulins in multiple sclerosis presumes combining of b-cell epitopes for diagnostics: a case-control study. Frontiers in immunology 28 (15): 1401156. https:\/\/doi.org\/10.3389\/fimmu.2024.1401156.","journal-title":"Frontiers in immunology"},{"key":"2284_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105478","volume":"85","author":"C Liu","year":"2024","unstructured":"Liu, C., W.X. Zhou, X. Sun, X. Zhang, H. Xiao, H. Yang, H. Lin, et al. 2024. Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis. Multiple sclerosis and related disorders 85: 105478. https:\/\/doi.org\/10.1016\/j.msard.2024.105478.","journal-title":"Multiple sclerosis and related disorders"},{"issue":"1","key":"2284_CR74","doi-asserted-by":"publisher","first-page":"200052","DOI":"10.1212\/NXI.0000000000200052","volume":"10","author":"C Barro","year":"2023","unstructured":"Barro, C., B.C. Healy, Y. Liu, S. Saxena, A. Paul, M. Polgar-Turcsanyi, C.R.G. Guttmann, et al. 2023. Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis. Neurology(R) Neuroimmunology & Neuroinflammation 10 (1): 200052. https:\/\/doi.org\/10.1212\/NXI.0000000000200052.","journal-title":"Neurology(R) Neuroimmunology & Neuroinflammation"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02284-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02284-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02284-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:12:21Z","timestamp":1762881141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02284-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02284-7","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Scientific Research Ethics Committee of the Faculty of Pharmacy, Helwan University, in March 2022, under approval number 03H2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All participants provided written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}